Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.34 |
| ▸ | MCL1 | Q07820 | 5/20 | 0.33 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.33 |
| ▸ | ADK | P55263 | 1/20 | 0.31 |
| ▸ | PRKDC | P78527 | 2/20 | 0.31 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.31 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.31 |
| ▸ | GPR3 | P46089 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22100002 | 0.90 | PARP14 (0.39) | ALOX5DUSP3PARP14ADKPRKDC | |
| SCHEMBL22074640 | 0.85 | ALOX5 (0.33) | ALOX5DUSP3MCL1GPR3 | |
| SCHEMBL17997058 | 0.85 | ALOX5 (0.36) | ALOX5DUSP3MCL1PARP14ADK | |
| SCHEMBL22100039 | 0.85 | ALOX5 (0.33) | ALOX5DUSP3PARP14PRKDCPIK3CD | |
| SCHEMBL21316763 | 0.85 | GPR3 (0.39) | ALOX5PARP14GPR3 | |
| SCHEMBL22074656 | 0.84 | TP53 (0.33) | ALOX5DUSP3MCL1PRKDCGPR3 | |
| SCHEMBL22409585 | 0.83 | ACHE (0.32) | ALOX5MCL1PARP14GPR3 | |
| SCHEMBL22100025 | 0.83 | ALOX5 (0.34) | ALOX5DUSP3PARP14PRKDCPIK3CD | |
| SCHEMBL22100157 | 0.83 | PRKDC (0.34) | ALOX5DUSP3PARP14PRKDCPIK3CD | |
| SCHEMBL22100029 | 0.83 | ALOX5 (0.36) | ALOX5DUSP3PARP14PRKDCPIK3CD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11834459-B2 | Host materials for electroluminescent devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-12-05 | — | — | US | disclosed |
| US-11834459-B2 | Host materials for electroluminescent devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-12-05 | — | — | US | disclosed |
| US-20200190103-A1 | HOST MATERIALS FOR ELECTROLUMINESCENT DEVICES | UNIVERSAL DISPLAY CORPORATION | 2020-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200190103-A1 | HOST MATERIALS FOR ELECTROLUMINESCENT DEVICES | RPS4X, MLX, RPS4Y1 | ALOX5 3051/4885DUSP3 2417/4885MCL1 1912/4885 |
| US-11834459-B2 | Host materials for electroluminescent devices | RPS4X, MLX, RPS4Y1 | ALOX5 3051/4885DUSP3 2417/4885MCL1 1912/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.